OMEICOS raised €17M in a Series C round in Oct 2018. The company is based in Berlin, Germany. Investors in the round: Forbion Capital Partners, SICAR, Vesalius Biocapital Partners. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €17M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
